Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$43.56
-5.38%
Mkt Cap $2.70B
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (10 analysts)
$65.00
Range $65.00 – $65.00
Implied Upside
+49.2%
Consensus $65.00 vs current $43.56